Full Text View
Tabular View
No Study Results Posted
Related Studies
Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)
This study has been terminated.
( Sponsor stopped due to difficulties to recruit 130 patients required by protocol )
Study NCT00324558   Information provided by Clinica Universidad de Navarra, Universidad de Navarra

First Received on May 9, 2006.   Last Updated on June 7, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Carcinoma, Small Cell
Additional conditions recognized in this trial
Carcinoma
Lung Neoplasms
Small Cell Lung Carcinoma
More general conditions related to this trial
Bronchial Neoplasms
Carcinoma, Bronchogenic
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Interventions listed in this trial
Bemiparin
Sponsors listed in this trial
Clinica Universidad de Navarra, Universidad de Navarra


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services